Zerlasiran

Ongoing Trials

Evaluate SLN360 in participants with elevated Lp(a) at high risk of atherosclerotic cardiovascular disease events (NCT05537571)

Completed Trials

Study to investigate safety, tolerability, PK and PD response of SLN360 in subjects with elevated lipoprotein(a) (APOLLO) (NCT0406602)

Educational Partners and Supporters